Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
RBB Bancorp
RBB
$446M
| $914K | ﹤0.01% |
42,753
-3,094
| -7% | -$66.3K |
|
2927
Ponce Financial Group
PDLB
$489M
| $912K | ﹤0.01% |
54,572
-5,981
| -10% | -$98.6K |
|
2928
Capital Bancorp
CBNK
$588M
| $912K | ﹤0.01% |
30,657
-4,639
| -13% | -$139K |
|
2929
First Bank
FRBA
$451M
| $912K | ﹤0.01% |
56,972
-6,036
| -10% | -$98.8K |
|
2930
Fate Therapeutics
FATE
$281M
| $908K | ﹤0.01% |
756,273
-28,355
| -4% | -$34.5K |
|
2931
TechTarget
TTGT
$246M
| $907K | ﹤0.01% |
233,779
-9,529
| -4% | -$43.8K |
|
2932
Ranger Energy Services
RNGR
$373M
| $904K | ﹤0.01% |
52,752
-2,220
| -4% | -$36K |
|
|
TECX
2933
Tectonic Therapeutic
TECX
$573M
| $900K | ﹤0.01% |
29,110
-3,351
| -10% | -$82.5K |
|
|
LUCK
2934
Lucky Strike Entertainment
LUCK
$938M
| $896K | ﹤0.01% |
107,718
+530
| +0.5% | +$4.38K |
|
|
GOOS
2935
Canada Goose Holdings
GOOS
$868M
| $895K | ﹤0.01% |
81,778
+7,342
| +10% | +$88.3K |
|
2936
Alto Ingredients
ALTO
$360M
| $890K | ﹤0.01% |
183,783
+150,022
| +444% | +$476K |
|
2937
Rackspace Technology
RXT
$1B
| $888K | ﹤0.01% |
906,459
+182,443
| +25% | +$222K |
|
2938
Luxfer Holdings
LXFR
$460M
| $875K | ﹤0.01% |
71,821
-6,719
| -9% | -$93.5K |
|
2939
Farmers & Merchants Bancorp
FMAO
$426M
| $871K | ﹤0.01% |
33,941
-4,221
| -11% | -$110K |
|
2940
MeiraGTx Holdings
MGTX
$1.09B
| $868K | ﹤0.01% |
100,194
-11,228
| -10% | -$85.3K |
|
2941
Stoneridge
SRI
$209M
| $857K | ﹤0.01% |
177,373
+26,100
| +17% | +$179K |
|
2942
Frequency Electronics
FEIM
$715M
| $856K | ﹤0.01% |
19,335
-1,852
| -9% | -$94.6K |
|
2943
NVE Corp
NVEC
$569M
| $855K | ﹤0.01% |
13,047
-1,366
| -9% | -$92K |
|
|
XOMA
2944
DELISTED
Xoma
XOMA
| $852K | ﹤0.01% |
27,151
-2,224
| -8% | -$59.6K |
|
|
CMDB
2945
Costamare Bulkers Holdings
CMDB
$457M
| $850K | ﹤0.01% |
54,921
-2,452
| -4% | -$41.2K |
|
2946
RE/MAX Holdings
RMAX
$200M
| $846K | ﹤0.01% |
146,921
-7,592
| -5% | -$52.5K |
|
2947
Norwood Financial Corp
NWFL
$355M
| $844K | ﹤0.01% |
28,676
+4,358
| +18% | +$128K |
|
|
SRTA
2948
Strata Critical Medical Inc
SRTA
$436M
| $844K | ﹤0.01% |
201,808
+6,892
| +4% | +$33.2K |
|
2949
ADC Therapeutics
ADCT
$146M
| $841K | ﹤0.01% |
224,361
+11,693
| +5% | +$46.1K |
|
2950
Viemed Healthcare
VMD
$451M
| $839K | ﹤0.01% |
91,101
-8,461
| -8% | -$70.4K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.